Home/Redefining cardiac care with next generation high sensitivity-Troponin (hs-Tn) assay

Redefining cardiac care with next generation high sensitivity-Troponin (hs-Tn) assay

Webinar
Live Webinar

Redefining cardiac care with next generation high sensitivity-Troponin (hs-Tn) assay

Date: 29th September 2026
Time: 14:00-15:00 (GMT+8)
Register for the Webinar
Decode Lung: Navigating New Biomarkers and Liquid Biopsy - Roche

About Webinar

When managing suspected Acute Coronary Syndrome (ACS) in the Emergency settings, time is myocardium. Join leading global experts to explore the latest advancements in next-generation hs-TnT assays and their integration into the 5th Universal Definition of Myocardial Infarction (5th UDMI). The session is tailored for frontline clinicians, cardiologists, and laboratory specialists. It explores the breakthrough clinical and operational benefits of the next-generation hs-TnT assay in managing ACS. Discover how leveraging these advanced analytical capabilities can reduce Emergency Department (ED) bottlenecks, streamline lab workflows, and accelerate time-to-diagnosis, transforming operational speed into life-saving clinical outcomes.

Moving to next-generation high-sensitivity testing isn’t just upgrading a laboratory reagent — it is a fundamental evolution in how we manage the entire acute care patient journey!



Key Takeaways

  • 1
    Understand recent advancements in hs-Tn testing and key updates in clinical guidelines, including the 5th UDMI.
  • 2
    Understand how analytical enhancements in next-generation hs-Tn assays may address pre-analytical and diagnostic challenges in the laboratory.
  • 3
    Explore ways to implement optimized, rapid hs-Tn diagnostic pathways to reduce ED bottlenecks and accelerate decision-making for suspected ACS patients.

Who Should Attend

This session is highly relevant for:
  • ER physicians
  • cardiologists
  • laboratory professionals

29th September, 2026
14:00 – 15:00 (GMT+8)

Faculty

Prof Kristin Aakre
Speaker
Prof Kristin Aakre
Professor in Laboratory Medicine
University of Bergen, Norway
View Bio

Prof Kristin Moberg Aakre is full Professor in Laboratory Medicine at the University of Bergen and a Consultant in Medical Biochemistry at Haukeland University Hospital. She is a specialist in medical biochemistry with a PhD focused on kidney biomarkers in primary care. Her research centers on cardiovascular biomarkers, diagnostic strategies for acute coronary syndromes, long-term prognostication and the implementation of high‑sensitivity troponin testing, including point‑of‑care solutions.

Aakre has authored more than 110 peer‑reviewed publications and holds an H‑index of 24. She leads major research initiatives such as the WESTCOR and WESTCOR‑POC studies, and has secured substantial competitive funding from the Western Norway Regional Health Authority, the Trond Mohn Foundation, and the Research Council of Norway.

Internationally, she contributes through key positions in the EFLM and is currently serving ac chair for the IFCC Committee on Clinical Application of Cardiac Biomarkers. She is a former Associate Editor of Clinical Biochemistry. She is an experienced supervisor of master’s and PhD candidates and frequently serves as an evaluator, reviewer, and opponent for academic institutions across Europe

Prof Martin Than
Speaker
Prof Martin Than
Emergency Medicine Specialist and Director of Emergency Medicine Research
Christchurch Hospital, New Zealand
View Bio

Prof Martin Than has a strong interest in evidence-based diagnosis and has tutored at The Centre for Evidence-Based Medicine in Oxford. His research interest is centred on quality improvement initiatives for the emergency department, focusing on cardiac biomarkers. His work has had a major international impact on the diagnosis and management of patients presenting to emergency departments with suspected heart attacks and has enabled emergency physicians around the world to diagnose or rule out heart attacks more rapidly and safely.

Martin was the principal investigator of the 3,500 patient ASPECT study, involving nine countries in the Asia-Pacific region, and of a randomized controlled trial of a 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department. Over the last two years he ran a 50,000+ patient implementation RCT using high sensitivity point of care troponin. Martin was an inaugural a member of the International Federation Committee on Clinical Applications of Cardiac Bio-Markers. He was the winner of the inaugural Beaven Medal for excellence in Health Service Delivery research and is currently undertaking a Health Research Council of NZ fellowship supporting cardiovascular disease research.

Associate Professor Jack Tan
Moderator
Associate Professor Jack Tan
Deputy Chief Executive Officer & Senior Consultant,
Department of Cardiology, National Heart Centre Singapore
View Bio

Associate Professor Jack Tan is the head of cardiology at the National Heart Centre Singapore. He is also the vice chairman at Singapore Heart Foundation.

He held the position of president of SCS (Singapore Cardiac Society), ISCP (International Society of Cardiovascular Pharmacotherapy) and APSC (Asian Pacific Society of Cardiology).

Agenda

Time (GMT+8) Topic Speaker
14:00–14:05 Opening and Welcome Associate Professor Jack Tan
14:05 – 14:25 Future-proof and reshape ACS workflow with advancements in hs-Tn Prof Kristin Aakre
14:25 – 14:45 State-of-the-art update on use of hs-Tn in ED and the new 5th UDMI Prof Martin Than
14:45 – 14:55 Q & A and Polling All
14:55 – 15:00 Closing Associate Professor Jack Tan
Local Time Reference:
GMT+08:0014:00 – 15:00
Karachi11:00 – 12:00
New Delhi11:30 – 12:30
Bangkok / Ho Chi Minh / Jakarta13:00 – 14:00
HK / KL / Singapore14:00 – 15:00
Seoul / Tokyo15:00 – 16:00
Melbourne16:00 – 17:00
New Zealand19:00 – 20:00

Secure Your Place

Join our prestigious panel of experts for this clinical update.

Register Now for Free